| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/16/2001 | EP1123710A1 Freeze-dried hepatitis a attenuated live vaccine and its stabilizer |
| 08/16/2001 | EP1123403A1 OMP85 PROTEINS OF $i(NEISSERIA GONORRHOEAE) AND $i(NEISSERIA MENINGITIDIS), COMPOSITIONS CONTAINING SAME AND METHODS OF USE THEREOF |
| 08/16/2001 | EP1123396A2 Minimal promoters and uses thereof |
| 08/16/2001 | EP1123395A2 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same |
| 08/16/2001 | EP1123392A1 Prv-1 gene and the use thereof |
| 08/16/2001 | EP1123387A2 Mn gene and protein |
| 08/16/2001 | EP1123115A1 Treatment of trauma (ie graft rejection) with liposomes containing dna encoding for ctla4ig or for anti cd40l |
| 08/16/2001 | EP1123114A1 Virus-like particles for the induction of autoantibodies |
| 08/16/2001 | EP1123086A2 Artificial antigen-specific cells and related methods |
| 08/16/2001 | EP0759944B1 Target cell binding chimaeric peptides |
| 08/16/2001 | EP0698097B1 Production of antibodies or (functionalized) fragments thereof derived from heavy chain immunoglobulins of camelidae |
| 08/16/2001 | EP0552256B1 Method of treating or preventing type 1 diabetes by oral administration of insulin |
| 08/16/2001 | DE10005643A1 Kombination eines Antigens mit einem Sulphatase-Inhibitor Combination of an antigen with a sulphatase inhibitor |
| 08/16/2001 | CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2400583A1 Porcine reproductive and respiratory syndrome virus and methods of use |
| 08/16/2001 | CA2400488A1 Methods for the prevention and treatment of infections using anti-c3b(i) antibodies |
| 08/16/2001 | CA2400299A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | CA2399969A1 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof |
| 08/16/2001 | CA2399939A1 Partners of ptb1 domain of fe65, preparation and uses |
| 08/16/2001 | CA2399593A1 Antibodies to ccr5 |
| 08/16/2001 | CA2399486A1 Use of compatible solutes as inhibitors of the enzymatic decomposition of macromolecular biopolymers |
| 08/16/2001 | CA2399436A1 Method of treating or inhibiting cellular injury or cell death |
| 08/16/2001 | CA2399391A1 Trade molecules and uses related thereto |
| 08/16/2001 | CA2399387A1 Heterologous polypeptide of the tnf family |
| 08/16/2001 | CA2399148A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2399019A1 Proteins producing an altered immunogenic response and methods of making and using the same |
| 08/16/2001 | CA2398136A1 Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| 08/16/2001 | CA2397254A1 Interferon-alpha induced genes |
| 08/15/2001 | CN1308679A Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases |
| 08/15/2001 | CN1308677A Human tumour-derived polyptde hormone phosphatonin |
| 08/15/2001 | CN1308676A Antibodies to CD23, derivatives thereof, and their therapeutic uses |
| 08/15/2001 | CN1308675A Immunological reagent specifically interating with the extracellular domain of the human zeta chain |
| 08/15/2001 | CN1308671A Myelin basic protein peptides and uses thereof |
| 08/15/2001 | CN1308637A Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 08/15/2001 | CN1308547A Novel compositions |
| 08/15/2001 | CN1308546A Immunomodulators for vaccines |
| 08/15/2001 | CN1307903A Vaccine wine oil adjuvant |
| 08/15/2001 | CN1307902A Varicella preventing method using vaccine |
| 08/14/2001 | US6274629 Use for 1,3-propanediol derivatives |
| 08/14/2001 | US6274376 An isolated polynucleotide encoding an atp depentent protease; therapy and diagnosis of respiratory diseases, central nervous systems disorders, septic arthritis, skin disorders and toxic shock syndrome |
| 08/14/2001 | US6274364 An isolated protease present in healthy stratum corneum; therapy and treatment of afflictions such as eczema, rosacea, psoriasis, lichens, severe pruritus and ichthyosis |
| 08/14/2001 | US6274361 A polynucleotide encoding a polypeptide sequence for a peptidyl-trna hydrolase; diagnosis and therapy for staphylococcal infections; screening antibiotics, vaccines |
| 08/14/2001 | US6274359 Amino acid sequence; for recombinant production of enzyme and production of 1-alpha, 25-dihydroxyvitamin d3; prevention, diagnosis and treatment of osteoporosis |
| 08/14/2001 | US6274347 Contacting antibody producing cells with fusion protein of extracellular portion of human leukocyte adhesion molecule-1 and constant region of human immunoglobulin g1, then isolating antibodies |
| 08/14/2001 | US6274322 Transfection kit; for use as nucleotide sequence tool during genetic engineering |
| 08/14/2001 | US6274149 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
| 08/14/2001 | US6274148 Hepatitis C virus asialoglycoproteins |
| 08/14/2001 | US6274147 Preparing cdna of infectious pancreatic necrosis virus genome, initiating replication of ds rna in host cell using rna derived from cdna, incubating host cell in culture medium, and isolating live, infectious pancreatic necrosis virus |
| 08/14/2001 | US6274145 To generate cytolytic t cells against abnormal cells; as markers for pathological or abnormal condition in diagnosis |
| 08/14/2001 | US6274144 Method for generating antibodies to saccharide fragments |
| 08/14/2001 | US6274143 Methods of delaying development of HMFG-associated tumors using anti-idiotype antibody 11D10 |
| 08/14/2001 | US6274142 Neutralizing coagulant activity of tissue factor by administering antibody which binds to tissue factor protein and neutralizes |
| 08/14/2001 | US6274139 For therapy of bacterial infections |
| 08/14/2001 | US6274134 Human cell adhesion protein AAMP-1 and uses thereof |
| 08/14/2001 | US6274117 Cytokines that bind the cell surface receptor Hek |
| 08/14/2001 | CA2243570C Mixture of recombinant vaccinia vectors as polyenv vaccines for hiv |
| 08/14/2001 | CA1341285C Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines |
| 08/10/2001 | CA2331876A1 Water-soluble ligand-binding proteins and analogs of ligand-gated channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 08/09/2001 | WO2001057226A1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 08/09/2001 | WO2001057207A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 08/09/2001 | WO2001057194A2 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 08/09/2001 | WO2001057090A1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody |
| 08/09/2001 | WO2001057077A1 Proteins that are specifically expressed or highly overexpressed in tumors and nucleic acids encoding them |
| 08/09/2001 | WO2001057075A2 Virulence genes, proteins, and their use |
| 08/09/2001 | WO2001057074A1 Ligands for fpr class receptors that induce a host immune response to a pathogen or inhibit hiv infection |
| 08/09/2001 | WO2001057073A2 Infectious cdna clone of hepatitis e virus (hev) genome, its production and uses |
| 08/09/2001 | WO2001057068A1 Mucin-1 derived antigens and their use in immunotherapy |
| 08/09/2001 | WO2001057065A2 Combinatorial protein domains |
| 08/09/2001 | WO2001057060A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 08/09/2001 | WO2001057056A1 Pharmaceutical compositions and methods for treating rheumatoid arthritis |
| 08/09/2001 | WO2001056611A1 Oral delivery of allergens in milk |
| 08/09/2001 | WO2001056608A1 Human herpesvirus 6a and 6b transfer factors for the treatment of chronic fatigue syndrome and multiple sclerosis |
| 08/09/2001 | WO2001056605A1 Porin b (porb) as a threrapeutic target for prevention and treatment of infection by chlamydia |
| 08/09/2001 | WO2001056603A1 Cd40-binding apc-activating molecules |
| 08/09/2001 | WO2001056602A2 Cd40 ligand adjuvant for respiratory syncytial virus |
| 08/09/2001 | WO2001056601A2 Low dose haptenized tumor cell and tumor cell extract immunotherapy |
| 08/09/2001 | WO2001056600A1 Method of controlling the qualities of attenuated pox vaccine |
| 08/09/2001 | WO2001056599A2 Hyperthermia and immunotherapy for leukemias, lymphomas, and solid tumors |
| 08/09/2001 | WO2001056598A2 Methods for preventing or attenuating pathoangiogenic conditions by using gbs-toxin (cm101) |
| 08/09/2001 | WO2001056387A1 Immunotherapeutic treatment methodology for patients afflicted with superficial bladder cancer who previously failed at least one immunostimulatory therapeutic treatment regimen |
| 08/09/2001 | WO2001056355A2 Human immunodeficiency virus vaccine |
| 08/09/2001 | WO2001027335A8 A novel adjuvant |
| 08/09/2001 | WO2001021796A3 Gl50 molecules and uses therefor |
| 08/09/2001 | WO2001010901A3 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 08/09/2001 | WO2001009287A3 Pressure treatment of cells |
| 08/09/2001 | WO2001007568A3 Muscle cells and their use in cardiac repair |
| 08/09/2001 | WO2001004318A3 Myxoma virus genes for immune modulation |
| 08/09/2001 | WO2001004316A3 Antigenic meningococcal peptides |
| 08/09/2001 | WO2001000796A3 Glycosyltransferases of helicobacter pylori |
| 08/09/2001 | WO2000077216A3 Porcine circovirus vaccine in recombinant poxvirus |
| 08/09/2001 | WO2000074729A3 Alpha or beta emitters to fragments in radioimmunotherapy |
| 08/09/2001 | WO2000070046A9 Secreted polypeptides and corresponding polynucleotides |
| 08/09/2001 | WO2000062813A3 Cationic peg-lipids and methods of use |
| 08/09/2001 | WO2000037643A3 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 08/09/2001 | US20010013134 Transgenic mammal; polynucleotide containing pancreas promoter |
| 08/09/2001 | US20010012889 36 human secreted proteins |
| 08/09/2001 | US20010012632 Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response |
| 08/09/2001 | US20010012627 Neurotransmitter transporter SC6 |
| 08/09/2001 | US20010012626 Polynucleotides encoding Presenilin 1 (PS1); diagnosing a patient having an increased likelihood of contracting Alzheimer's disease |
| 08/09/2001 | US20010012610 Of biological specimens by true vitrification comprising dehydrating a biologically active material at a temperature higher than the suggested storage temperatures followed by cooling of the sample to the storage temperature |